
If you’re building a medtech startup in Houston, you already know the hard part isn’t just the device.
It’s getting evidence, fundraising, and outside partners to move in the same direction at the same time.
That’s exactly what Dr. Rafael Veraza of Vascular Perfusion Solutions will be digging into at TMC Innovation Factory’s Pints & Prototypes next Thursday, sponsored by Enlil.
His talk, The MedTech Startup Triangle: Evidence, Capital, and Partners, is built for founders, innovators, investors, and development partners who want fewer delays, less rework, and a cleaner path from prototype to traction.
If that sounds a bit too familiar, you should probably be in the room.
Register here: https://enlilinc.zohobackstage.com/TMC-Pints-and-Prototypes-May-2026
#HoustonMedTech #MedTechStartup #MedicalDevices #TMCInnovation #Founders #Innovation
It’s getting evidence, fundraising, and outside partners to move in the same direction at the same time.
That’s exactly what Dr. Rafael Veraza of Vascular Perfusion Solutions will be digging into at TMC Innovation Factory’s Pints & Prototypes next Thursday, sponsored by Enlil.
His talk, The MedTech Startup Triangle: Evidence, Capital, and Partners, is built for founders, innovators, investors, and development partners who want fewer delays, less rework, and a cleaner path from prototype to traction.
If that sounds a bit too familiar, you should probably be in the room.
Register here: https://enlilinc.zohobackstage.com/TMC-Pints-and-Prototypes-May-2026
#HoustonMedTech #MedTechStartup #MedicalDevices #TMCInnovation #Founders #Innovation
Shared byCameron Gray - 17 days ago
Log in to comment
Loading ..
Related Articles
Record Q1 2026: Eight MedTech Innovators Choose Enlil
Record Quarter for Enlil: Welcoming 8 New MedTech Innovators in Q1 2026
Join the Houston MedTech Community for a Practical Insight on Startup Challenges
Enlil Joins NEMIC as Corporate Member, Advances MedTech Innovation
Navigating MedTech Challenges in Houston: Evidence, Partners, and Capital Alignment
Enlil Partners with Celerity MedTech to Enhance MedTech Development Processes
9
0/100